Sten Holmang

Summary

Country: Sweden

Publications

  1. ncbi request reprint Prognostic factors in patients with carcinoma in situ treated with intravesical bacille Calmette-Guérin
    Patrik Andius
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Urol Nephrol 38:285-90. 2004
  2. ncbi request reprint Impact of diagnostic and treatment delay on survival in patients with renal pelvic and ureteral cancer
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Urol Nephrol 40:479-84. 2006
  3. ncbi request reprint Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Urology 66:274-8. 2005
  4. ncbi request reprint Bilateral metachronous ureteral and renal pelvic carcinomas: incidence, clinical presentation, histopathology, treatment and outcome
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    J Urol 175:69-72; discussion 72-3. 2006
  5. ncbi request reprint Micropapillary carcinoma of the renal pelvis and ureter
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    J Urol 175:463-6; discussion 466-7. 2006
  6. ncbi request reprint Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Cancer 101:741-7. 2004
  7. ncbi request reprint Completeness and correctness of registration of renal pelvic and ureteral cancer in the Swedish Cancer Registry
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Urol Nephrol 42:12-7. 2008
  8. ncbi request reprint Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital Goteborg, Sweden
    J Urol 178:51-6. 2007
  9. ncbi request reprint Tumours of the ureter and renal pelvis treated with resection and renal autotransplantation: a study with up to 20 years of follow-up
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Goteborg, S 413 45 Sweden
    BJU Int 95:1201-5. 2005
  10. doi request reprint Urinary diversion after cystectomy for bladder cancer: a population-based study in Sweden
    Staffan Jahnson
    Department of Urology, University Hospital, Linkoping, Sweden
    Scand J Urol Nephrol 44:69-75. 2010

Collaborators

Detail Information

Publications27

  1. ncbi request reprint Prognostic factors in patients with carcinoma in situ treated with intravesical bacille Calmette-Guérin
    Patrik Andius
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Urol Nephrol 38:285-90. 2004
    ..To report prognostic factors and follow-up data for an unselected group of patients with carcinoma in situ (CIS) of the urinary bladder treated with bacille Calmette-Guérin (BCG)...
  2. ncbi request reprint Impact of diagnostic and treatment delay on survival in patients with renal pelvic and ureteral cancer
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Urol Nephrol 40:479-84. 2006
    ..To investigate the relationships between diagnostic and treatment delay and tumour stage and survival among patients with malignant tumours in the renal pelvis and ureter...
  3. ncbi request reprint Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Urology 66:274-8. 2005
    ..Only a few bladder tumor studies have compared these systems...
  4. ncbi request reprint Bilateral metachronous ureteral and renal pelvic carcinomas: incidence, clinical presentation, histopathology, treatment and outcome
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    J Urol 175:69-72; discussion 72-3. 2006
    ..Metachronous bilateral UUTTs are rare. The authors reported baseline and long-term followup data for all patients diagnosed in Western Sweden during a 28-year period...
  5. ncbi request reprint Micropapillary carcinoma of the renal pelvis and ureter
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    J Urol 175:463-6; discussion 466-7. 2006
    ..MPC located in the upper urinary tract is rare with only 2 cases reported to date. We report clinical and histopathological data on 26 patients to increase the knowledge of this rare entity...
  6. ncbi request reprint Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Cancer 101:741-7. 2004
    ..Synchronous bilateral urothelial tumors of the upper urinary tract are very rare. The authors reported baseline and long-term follow-up data for all patients in western Sweden during a 28-year period...
  7. ncbi request reprint Completeness and correctness of registration of renal pelvic and ureteral cancer in the Swedish Cancer Registry
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Urol Nephrol 42:12-7. 2008
    ..To study the completeness and correctness of the Swedish Cancer Registry (SCR) for renal pelvic and ureteral carcinomas diagnosed in western Sweden...
  8. ncbi request reprint Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital Goteborg, Sweden
    J Urol 178:51-6. 2007
    ..Squamous cell carcinomas of the renal pelvis and ureter are rare. We report a large series of patients and compare it to patients with urothelial carcinoma...
  9. ncbi request reprint Tumours of the ureter and renal pelvis treated with resection and renal autotransplantation: a study with up to 20 years of follow-up
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Goteborg, S 413 45 Sweden
    BJU Int 95:1201-5. 2005
    ..To report long-term follow-up data from patients treated with resection of urothelial neoplasms of the upper urinary tract combined with autotransplantation of the kidney...
  10. doi request reprint Urinary diversion after cystectomy for bladder cancer: a population-based study in Sweden
    Staffan Jahnson
    Department of Urology, University Hospital, Linkoping, Sweden
    Scand J Urol Nephrol 44:69-75. 2010
    ..To investigate the type of urinary diversion performed after cystectomy in patients with muscle-invasive bladder cancer in Sweden, using data from a population-based national register...
  11. doi request reprint Long-term follow-up after radical cystectomy with emphasis on complications and reoperations: a Swedish population-based survey
    Fredrik Liedberg
    Department of Urology, Växjö County Hospital, Vaxjo, Sweden
    Scand J Urol Nephrol 46:14-8. 2012
    ..To evaluate outcome after radical cystectomy for primary bladder cancer in a large population-based material...
  12. ncbi request reprint Costs of radical cystectomy
    Ingela Berrum-Svennung
    Department of Urology, Sahlgrenska University Hospital, S 413 45 Goteborg, Sweden
    Scand J Urol Nephrol 39:36-41. 2005
    ..The aims of this study were to determine the costs of cystectomy, with and without complications, and to investigate related prognostic factors...
  13. doi request reprint Impact of hospital volume on local recurrence and distant metastasis in bladder cancer patients treated with radical cystectomy in Sweden
    Emad F Sabir
    Department of Urology, Institution for Medical Sciences, Linkoping University, Linkoping, Sweden
    Scand J Urol 47:483-90. 2013
    ..This study evaluated the impact of hospital volume on local recurrence and distant metastasis in a population-based series of radical cystectomy patients in Sweden...
  14. ncbi request reprint Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer
    Lennart Aström
    Department of Oncology, University of Gothenburg, Gothenburg, Sweden
    Radiother Oncol 74:157-61. 2005
    ..If the alpha/beta ratio is low for PC, hypofractionation will be of advantage. A retrospective analysis of outcome in patients (pts) consecutively treated with combined HDR-BT and conformal external beam radiotherapy (ERT) was performed...
  15. ncbi request reprint The cost of bladder tumour treatment and follow-up
    Hans Hedelin
    Department of Urology, Karnsjukhuset, Skovde, Sweden
    Scand J Urol Nephrol 36:344-7. 2002
    ..To evaluate the costs of bladder tumour treatment and follow-up...
  16. ncbi request reprint Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion
    Patrik Andius
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Urology 70:758-62. 2007
    ..We studied the prognostic factors for progression and disease-specific survival in patients with Stage T1 bladder cancer to identify subgroups with different prognoses...
  17. ncbi request reprint Routine postoperative urography after cystectomy and urinary diversion is not necessary
    Ingela Berrum-Svennung
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Urol Nephrol 39:211-3. 2005
    ..We registered the frequency of significant findings at routine postoperative urography in patients with bladder cancer treated with radical cystectomy and urinary diversion...
  18. ncbi request reprint Intravesical bacillus Calmette-Guèrin therapy: experience with a reduced dwell-time in patients with pronounced side-effects
    Patrik Andius
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    BJU Int 96:1290-3. 2005
    ....
  19. doi request reprint Should follow-up cystoscopy in bacillus Calmette-Guérin-treated patients continue after five tumour-free years?
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Eur Urol 61:503-7. 2012
    ..It is not known how long follow-up cystoscopy in tumour-free bacillus Calmette-Guérin (BCG)-treated patients should continue...
  20. doi request reprint A population-based study of patterns of care for muscle-invasive bladder cancer in Sweden
    Staffan Jahnson
    Department of Urology, University Hospital, Linkoping, Sweden
    Scand J Urol Nephrol 43:271-6. 2009
    ..e. cystectomy or radiotherapy) in relation to patient, tumour and hospital characteristics...
  21. doi request reprint Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study
    Martin C Schumacher
    Department of Molecular Medicine and Surgery, Karolinska Institutet, Department of Urology, Stockholm, Sweden
    Eur Urol 57:293-9. 2010
    ..Most reports are from single centres with relatively few patients...
  22. ncbi request reprint A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences
    Ingela Berrum-Svennung
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    J Urol 179:101-5; discussion 105-6. 2008
    ..We studied whether a single instillation of epirubicin after transurethral bladder tumor resection would influence the interval to and size of the first recurrence...
  23. ncbi request reprint Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    J Urol 167:1634-7. 2002
    ..We studied the relationship of first cystoscopy findings with recurrence and progression rates in a large, population based series of patients with bladder cancer...
  24. ncbi request reprint High-dose rate brachytherapy of prostatic adenocarcinoma in combination with external beam radiotherapy a long-term follow-up of the first 50 patients at one center
    Bo Lennernas
    Department of Oncology, Sahlgrenska University Hospital, Sweden
    Strahlenther Onkol 178:537-41. 2002
    ..To report the long-term follow-up of 50 patients with prostatic adenocarcinoma (PAC) treated by high-dose rate brachytherapy in combination with external beam radiotherapy...
  25. doi request reprint Long-term follow-up of patients with tumours of the renal pelvis and ureter: how often is a bladder tumour diagnosed after five tumour-free years?
    Sten Holmang
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden and Department of Pathology and Microbiology, University of Nebraska Medical Center, USA and Eppley Institute for Research in Cancer and Allied Diseases
    Scand J Urol 48:65-72. 2014
    ..The aim of this study was to investigate the length of the interval from surgery to diagnosis of the first bladder tumour...
  26. doi request reprint Late bacille Calmette-Guérin infection with a large focal urinary bladder ulceration as a complication of bladder cancer treatment
    Viveka Ströck
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    BJU Int 107:1592-7. 2011
    ..To report a late bacille Calmette-Guérin (BCG) complication previously not described in the literature...
  27. doi request reprint A randomized trial comparing 2 doses of polidocanol sclerotherapy for hydrocele or spermatocele
    Staffan Jahnson
    Department of Urology, Institution of Clinical and Experimental Medicine, Linkoping University, Linkoping, Sweden
    J Urol 186:1319-23. 2011
    ..We compared the efficacy and morbidity of 2 or 4 ml polidocanol sclerotherapy for hydrocele or spermatocele...